SCHEMBL22728863

SCHEMBL22728863

COC(=O)C(C=O)CC(=O)c1ccc(OC(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.47
▸ GFER P55789 1/20 0.47
▸ ADAM17 P78536 1/20 0.47
▸ RAB9A P51151 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MDM2 Q00987 1/20 0.45
▸ HDAC3 O15379 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC7 Q8WUI4 1/20 0.45
▸ HDAC2 Q92769 1/20 0.45
▸ HDAC10 Q969S8 1/20 0.45
▸ HDAC11 Q96DB2 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ HDAC9 Q9UKV0 1/20 0.45
▸ HDAC5 Q9UQL6 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ ATM Q13315 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19660155 0.86 HDAC8 (0.50) ALOX15ALDH1A1HDAC3HDAC4HDAC1
SCHEMBL19660002 0.83 ALOX15 (0.51) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL22728769 0.83 HDAC3 (0.44) RAB9AALDH1A1HDAC3HDAC4HDAC1
SCHEMBL23797050 0.82 ALOX15 (0.50) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL23797019 0.81 L3MBTL1 (0.55) RAB9AALDH1A1PKMHTTKDM4E
SCHEMBL10455298 0.76 HDAC3 (0.54) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL23617221 0.74 ALOX15 (0.54) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL19642631 0.73 ATM (0.54) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL10883891 0.73 HDAC3 (0.60) ALOX15GFERADAM17RAB9AALDH1A1
SCHEMBL20487435 0.73 ALOX15 (0.53) ALOX15GFERADAM17RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3580211-B1 2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER BAYER AG (DE) 2020-12-02 — — EP disclosed
Send feedback